ProfileGDS5822 / ILMN_2898886
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 30% 22% 16% 25% 4% 55% 15% 9% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.330
GSM1276600PDAC Late Ablation Control 215.322
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 110.416
GSM1276603PDAC Late Ablation 213.725
GSM1276604PDAC Late Ablation 35.14
GSM1303940PDAC Late Ablation_anti-CTLA4 124.755
GSM1303941PDAC Late Ablation_anti-CTLA4 2915
GSM1303942PDAC Late Ablation_anti-CTLA4 36.19